Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 1381-1400 of 2,731 trials

Expanded Access Protocol Using 131I-MIBG

NCT01590680

Protocol JDI2007-01 is an Expanded Access Protocol with therapeutic 131I-MIBG for patients with neuroblastoma or pheochromocytoma / paraganglioma, who otherwise do not qualify for available treatments, or where approved treatment is not commercially available.

NeuroblastomaPheochromocytomaParaganglioma

Jubilant DraxImage Inc.

Los Angeles, California, United States • Aurora, Colorado, United States • Atlanta, Georgia, United States +16 more locations

COMPLETEDPhase 3< 1 mile

A Phase 3 Study of NI-071 in Participants With Rheumatoid Arthritis (RADIANCE)

NCT02990806

The purpose of this study was to demonstrate similarity of NI-071 (proposed biosimilar to infliximab) to US REMICADE® (reference product) in terms of safety and efficacy in participants with rheumatoid arthritis (RA) not adequately responding to methotrexate (MTX).

Rheumatoid Arthritis

Nichi-Iko Pharmaceutical Co., Ltd.683 participantsStarted Jan 2017

Little Rock, Arkansas, United States • Los Angeles, California, United States • Los Angeles, California, United States +131 more locations

Expanded Access Protocol Using 131I-MIBG

A Phase 3 Study of NI-071 in Participants With Rheumatoid Arthritis (RADIANCE)

Rheumatoid Arthritis Trials in Other Cities

Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration

An Open-label Safety and Pharmacokinetic Study of INL-001 in Adults Following Various Open Soft-Tissue Surgeries

Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder

Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy

A Study Assessing AR-13503 Implant in Subjects With nAMD or DME

Sonendo GentleWave™ System for Treatment in Molar Teeth Requiring Root Canal Therapy

Safety and Efficacy in Adult Subjects With Acute Migraines

Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine

Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer

A Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-079 Administered Subcutaneously as a Single Agent in Participants With Relapsed/Refractory (r/r) Multiple Myeloma (MM)

Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma

Trial in Adult Subjects With Acute Migraines

Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion

Thoracolumbar Burst Fractures Study Comparing Surgical Versus Non-surgical Treatment

Spinal Cord Stimulation in the Treatment of Chronic, Intractable Pain Using the Nalu™ Neurostimulation System

Characterization & Treatment of Chronic Pain After Moderate to Severe TBI

Other Conditions in Los Angeles